Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 19, 2026

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection
08:09

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection

Published on: July 25, 2017

Current and future developments in screening for ovarian cancer.

Nicole Urban1, Charles Drescher

  • 1Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, M2-B230 Seattle, WA 98109, USA. nurban@fhcrc.org.

Women'S Health (London, England)
|October 7, 2009
PubMed
Summary

Early detection of ovarian cancer is crucial. New biomarker research aims to identify curable tumors before symptoms arise, improving survival rates for this often advanced disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacological modulation of TRPV2 enhances migration and induces Immunoglobulin E (IgE)-independent degranulation of mast cells.

Cell calcium·2026
Same author

O-linked glycan-dependent gating of TPC2 controls lysosomal excitability and organelle remodeling.

Nature communications·2026
Same author

Ideal efficacy photoswitching for chromocontrol of TRPC4/5 channel functions in live tissues.

Nature chemical biology·2026
Same author

Activation of TRPV3 channels in bladder cancer cells stimulates ATP release.

Molecular pharmacology·2025
Same author

De novo variants in ATP2B1 lead to neurodevelopmental delay.

American journal of human genetics·2025
Same author

Identification and optimization of a small molecule inhibitor of the ovarian tumor protease of the Crimean-Congo hemorrhagic fever virus.

Bioorganic & medicinal chemistry·2025

Area of Science:

  • Gynecology
  • Oncology
  • Biomarker Research

Background:

  • Ovarian cancer survival rates are significantly lower when diagnosed at advanced stages compared to localized disease.
  • Current screening is limited to high-risk populations and often fails to detect early-stage, curable tumors.
  • Existing screening methods can lead to unnecessary surgeries due to the detection of benign ovarian conditions.

Purpose of the Study:

  • To investigate novel biomarkers for the early detection of ovarian cancer.
  • To develop a marker panel for selecting women who may benefit from imaging or surgery.
  • To address the clinical challenge of definitive diagnosis requiring invasive surgery.

Main Methods:

  • Investigating new potential biomarkers for early ovarian cancer detection.

More Related Videos

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
13:04

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

Related Experiment Videos

Last Updated: Jun 19, 2026

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection
08:09

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection

Published on: July 25, 2017

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
13:04

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

  • Exploring the use of marker panels to identify women for further diagnostic procedures.
  • Addressing the need for preclinical blood samples for translational biomarker research.

    • Main Results:

    • New markers are under investigation that may signal disease earlier.
    • A marker panel could potentially select women for imaging and/or surgery.
    • Access to preclinical blood samples is essential for validating early detection markers.

    Conclusions:

    • Improved early detection of ovarian cancer through novel biomarkers is critical for enhancing patient survival.
    • Biomarker panels hold promise for more accurate patient selection for diagnostic procedures.
    • Further translational research is needed to validate biomarkers using preclinical samples for effective early detection strategies.